Skip to main content

Table 1 The baseline characteristics of gastric carcinoma patients (n = 40)

From: The role of miR-485-5p/NUDT1 axis in gastric cancer

 

NUDT1-positive (n = 31)

No. of patients (%)

NUDT1-negative (n = 9)

No. of patients (%)

P value

Gender

  

1.000

 Male

22 (71.0)

7 (77.8)

 

 Female

9 (29.0)

2 (22.2)

 

Age

  

1.000

 ≤ 65

26 (83.9)

7 (77.8)

 

 > 65

5 (16.1)

2 (22.2)

 

Borrmann

  

1.000

 Type I

1 (3.2)

0 (0.0)

 

 Type II

17 (54.9)

5 (55.6)

 

 Type III

12 (38.7)

4 (44.4)

 

 Type IV

1 (3.2)

0 (0.0)

 

Differentiation

  

0.643

 Well/moderately

8 (25.8)

1 (11.1)

 

 Poorly

23 (74.2)

8 (88.9)

 

T stage

  

0.004

 T1a/T1b

0 (0.0)

2 (22.2)

 

 T2

1 (3.2)

2 (22.2)

 

 T3

1 (3.2)

1 (11.1)

 

 T4a

29 (93.6)

4 (44.5)

 

N stage

  

0.157

 N0

12 (38.7)

2 (22.2)

 

 N1

2 (6.5)

3 (33.3)

 

 N2

8 (25.8)

3 (33.3)

 

 N3a/N3b

9 (29.0)

1 (11.2)

Â